AG˹ٷ

STOCK TITAN

[Form 4] Neogen Corp Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

Neogen Corp insider filing: John Patrick Moylan, identified as a director and Chief Accounting Officer, reported purchases on 08/15/2025. He acquired 18,416 shares of NEOG common stock at a price of $5.43 per share, bringing his total reported beneficial ownership to 31,371 shares. The filing also reports acquisition of derivative rights described as the right to buy 47,336 shares at a $5.43 exercise price, exercisable beginning 08/15/2025 and expiring 08/15/2035, with 47,336 underlying shares shown as beneficially owned following the transaction. The filing notes that options and restricted stock units vest in equal annual installments on each of the first three anniversary dates of the grants.

Comunicato interno di Neogen Corp: John Patrick Moylan, indicato come direttore e Chief Accounting Officer, ha segnalato acquisti effettuati il 15/08/2025. Ha acquistato 18.416 azioni ordinarie NEOG a 5,43$ ciascuna, portando la sua partecipazione beneficiaria totale a 31.371 azioni. La comunicazione riporta inoltre l'acquisizione di diritti derivati descritti come il diritto di acquistare 47.336 azioni a un prezzo di esercizio di 5,43$, esercitabile a partire dal 15/08/2025 e in scadenza il 15/08/2035, con 47.336 azioni sottostanti indicate come possedute dopo la transazione. Si segnala che opzioni e unità azionarie vincolate maturano in tre rate annuali uguali nelle prime tre ricorrenze anniversarie dei grant.

Presentación interna de Neogen Corp: John Patrick Moylan, identificado como director y Chief Accounting Officer, informó compras el 15/08/2025. Adquirió 18.416 acciones ordinarias de NEOG a 5,43$ por acción, elevando su propiedad beneficiaria reportada a 31.371 acciones. La presentación también informa la adquisición de derechos derivados descritos como el derecho a comprar 47.336 acciones a un precio de ejercicio de 5,43$, ejercitable desde el 15/08/2025 y con vencimiento el 15/08/2035, con 47.336 acciones subyacentes mostradas como beneficiarias tras la operación. Se indica que las opciones y las unidades restringidas de acciones vencen en importes iguales anuales en cada uno de los primeros tres aniversarios de las concesiones.

Neogen Corp 내부 공시: 이사이자 최고회계책임자로 표시� John Patrick Moylan은 2025-08-15� 매입� 보고했습니다. 그는 NEOG 보통� 18,416주를 주당 5.43달러� 취득하여 그의 신고� 실소� 총량� 31,371주로 늘렸습니�. 공시에는 또한 파생권리� 취득� 보고되어 있으�, 이는 행사 가� 5.43달러� 47,336주를 매수� 권리� 설명되며 2025-08-15부� 행사 가능하� 2035-08-15� 만료되며 거래 � 47,336주의 기초 주식� 실소유로 표시되어 있습니다. 공시에는 옵션 � 제한 주식 단위� 부여일� � � 번째 기념� 각각� 동일� 연간 분할� 권리가 확정된다� 명시되어 있습니다.

Déclaration d'initié de Neogen Corp : John Patrick Moylan, indiqué comme administrateur et Chief Accounting Officer, a déclaré des achats effectués le 15/08/2025. Il a acquis 18 416 actions ordinaires NEOG au prix de 5,43$ par action, portant sa détention bénéficiaire déclarée à 31 371 actions. La déclaration signale également l'acquisition de droits dérivés décrits comme le droit d'acheter 47 336 actions à un prix d'exercice de 5,43$, exerçable à partir du 15/08/2025 et expirant le 15/08/2035, avec 47 336 actions sous-jacentes indiquées comme détenues après la transaction. Il est précisé que les options et les unités d'actions restreintes acquièrent leurs droits en trois versements annuels égaux aux trois premiers anniversaires des attributions.

Insider-Meldung von Neogen Corp: John Patrick Moylan, ausgewiesen als Direktor und Chief Accounting Officer, meldete Käufe am 15.08.2025. Er erwarb 18.416 Stück NEOG-Stammaktien zu je 5,43$, wodurch sein gemeldetes wirtschaftliches Eigentum auf insgesamt 31.371 Aktien anstieg. Die Meldung berichtet außerdem über den Erwerb derivativer Rechte, beschrieben als das Recht zum Kauf von 47.336 Aktien zu einem Ausübungspreis von 5,43$, ausübbar ab dem 15.08.2025 und mit Ablauf am 15.08.2035; nach der Transaktion werden 47.336 zugrunde liegende Aktien als wirtschaftlich gehalten ausgewiesen. Es wird darauf hingewiesen, dass Optionen und Restricted Stock Units in gleichen jährlichen Raten an jedem der ersten drei Jahrestage der Gewährung vesten.

Positive
  • Insider purchased additional shares (18,416 acquired) indicating increased executive ownership
  • Clear vesting disclosure: options and RSUs vest in equal annual installments over three years
  • Derivative position disclosed (right to buy 47,336 shares at $5.43, exercisable through 08/15/2035), providing transparency on potential future dilution
Negative
  • None.

Insights

TL;DR: Insider acquisition increases executive stake but appears to be a routine grant vesting and exercise-related transaction.

The Form 4 shows a single reporting person, John Patrick Moylan, acquiring 18,416 shares at $5.43 and reporting beneficial ownership of 31,371 shares. In addition, Moylan reports derivative rights to purchase 47,336 shares at a $5.43 exercise price with a 2035 expiration date. These entries are consistent with scheduled option/RSU vesting rather than an open-market opportunistic purchase. The magnitude of the derivative position relative to current ownership is material at the individual level but no company-level metrics (total outstanding shares or percent ownership) are provided, so investor impact cannot be quantified from this filing alone.

TL;DR: Disclosure is timely and follows Section 16 reporting conventions; vesting schedule is explicitly stated.

The filing identifies the reporting person as both a director and an officer and discloses the vesting framework: options and RSUs vest in equal annual installments over the first three anniversaries. The presence of an attorney-in-fact signature indicates the filing was executed by an authorized representative. There are no governance red flags disclosed in this Form 4; it documents a standard executive compensation realization and associated beneficial ownership change.

Comunicato interno di Neogen Corp: John Patrick Moylan, indicato come direttore e Chief Accounting Officer, ha segnalato acquisti effettuati il 15/08/2025. Ha acquistato 18.416 azioni ordinarie NEOG a 5,43$ ciascuna, portando la sua partecipazione beneficiaria totale a 31.371 azioni. La comunicazione riporta inoltre l'acquisizione di diritti derivati descritti come il diritto di acquistare 47.336 azioni a un prezzo di esercizio di 5,43$, esercitabile a partire dal 15/08/2025 e in scadenza il 15/08/2035, con 47.336 azioni sottostanti indicate come possedute dopo la transazione. Si segnala che opzioni e unità azionarie vincolate maturano in tre rate annuali uguali nelle prime tre ricorrenze anniversarie dei grant.

Presentación interna de Neogen Corp: John Patrick Moylan, identificado como director y Chief Accounting Officer, informó compras el 15/08/2025. Adquirió 18.416 acciones ordinarias de NEOG a 5,43$ por acción, elevando su propiedad beneficiaria reportada a 31.371 acciones. La presentación también informa la adquisición de derechos derivados descritos como el derecho a comprar 47.336 acciones a un precio de ejercicio de 5,43$, ejercitable desde el 15/08/2025 y con vencimiento el 15/08/2035, con 47.336 acciones subyacentes mostradas como beneficiarias tras la operación. Se indica que las opciones y las unidades restringidas de acciones vencen en importes iguales anuales en cada uno de los primeros tres aniversarios de las concesiones.

Neogen Corp 내부 공시: 이사이자 최고회계책임자로 표시� John Patrick Moylan은 2025-08-15� 매입� 보고했습니다. 그는 NEOG 보통� 18,416주를 주당 5.43달러� 취득하여 그의 신고� 실소� 총량� 31,371주로 늘렸습니�. 공시에는 또한 파생권리� 취득� 보고되어 있으�, 이는 행사 가� 5.43달러� 47,336주를 매수� 권리� 설명되며 2025-08-15부� 행사 가능하� 2035-08-15� 만료되며 거래 � 47,336주의 기초 주식� 실소유로 표시되어 있습니다. 공시에는 옵션 � 제한 주식 단위� 부여일� � � 번째 기념� 각각� 동일� 연간 분할� 권리가 확정된다� 명시되어 있습니다.

Déclaration d'initié de Neogen Corp : John Patrick Moylan, indiqué comme administrateur et Chief Accounting Officer, a déclaré des achats effectués le 15/08/2025. Il a acquis 18 416 actions ordinaires NEOG au prix de 5,43$ par action, portant sa détention bénéficiaire déclarée à 31 371 actions. La déclaration signale également l'acquisition de droits dérivés décrits comme le droit d'acheter 47 336 actions à un prix d'exercice de 5,43$, exerçable à partir du 15/08/2025 et expirant le 15/08/2035, avec 47 336 actions sous-jacentes indiquées comme détenues après la transaction. Il est précisé que les options et les unités d'actions restreintes acquièrent leurs droits en trois versements annuels égaux aux trois premiers anniversaires des attributions.

Insider-Meldung von Neogen Corp: John Patrick Moylan, ausgewiesen als Direktor und Chief Accounting Officer, meldete Käufe am 15.08.2025. Er erwarb 18.416 Stück NEOG-Stammaktien zu je 5,43$, wodurch sein gemeldetes wirtschaftliches Eigentum auf insgesamt 31.371 Aktien anstieg. Die Meldung berichtet außerdem über den Erwerb derivativer Rechte, beschrieben als das Recht zum Kauf von 47.336 Aktien zu einem Ausübungspreis von 5,43$, ausübbar ab dem 15.08.2025 und mit Ablauf am 15.08.2035; nach der Transaktion werden 47.336 zugrunde liegende Aktien als wirtschaftlich gehalten ausgewiesen. Es wird darauf hingewiesen, dass Optionen und Restricted Stock Units in gleichen jährlichen Raten an jedem der ersten drei Jahrestage der Gewährung vesten.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Moylan John Patrick

(Last) (First) (Middle)
620 LESHER PLACE

(Street)
LANSING MI 48912

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
NEOGEN CORP [ NEOG ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Accounting Officer
3. Date of Earliest Transaction (Month/Day/Year)
08/15/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 08/15/2025 A 18,416(1) A $5.43 31,371 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Common Stock (Right to Buy) $5.43 08/15/2025 A 47,336 (1) 08/15/2035 Common Stock 47,336 $0 47,336 D
Explanation of Responses:
1. Options and RSUs vest in equal annual installments on each of the first three anniversary dates of the grants
Christopher Sefcheck (Attorney in Fact) 08/19/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transaction did NEOG insider John Patrick Moylan report on Form 4?

He reported acquiring 18,416 shares of NEOG common stock on 08/15/2025 at a price of $5.43 per share.

How many NEOG shares does John Patrick Moylan beneficially own after the reported transaction?

The Form 4 reports 31,371 shares beneficially owned following the transaction.

What derivative securities did the filing disclose for NEOG (ticker: NEOG)?

The filing discloses a right to buy 47,336 shares with an exercise price of $5.43, exercisable starting 08/15/2025 and expiring 08/15/2035.

What is the vesting schedule described in the Form 4 for the options and RSUs?

The filing states options and RSUs vest in equal annual installments on each of the first three anniversary dates of the grants.

Who signed the Form 4 and when was it filed?

The Form 4 was signed by an attorney-in-fact, Christopher Sefcheck, on 08/19/2025.
Neogen Corp

NASDAQ:NEOG

NEOG Rankings

NEOG Latest News

NEOG Latest SEC Filings

NEOG Stock Data

1.25B
214.72M
0.85%
112.75%
7.94%
Diagnostics & Research
In Vitro & in Vivo Diagnostic Substances
United States
LANSING